Abstract
Carbon dioxide (CO2), the major product of metabolism, has a strong impact on cerebral blood vessels, a phenomenon known as cerebrovascular reactivity. Several vascular risk factors such as hypertension or diabetes dampen this response, making cerebrovascular reactivity a useful diagnostic marker for incipient vascular pathology, but its functional relevance, if any, is still unclear. Here, we found that GPR4, an endothelial H+ receptor, and endothelial Gαq/11 proteins mediate the CO2/H+ effect on cerebrovascular reactivity in mice. CO2/H+ leads to constriction of vessels in the brainstem area that controls respiration. The consequential washout of CO2, if cerebrovascular reactivity is impaired, reduces respiration. In contrast, CO2 dilates vessels in other brain areas such as the amygdala. Hence, an impaired cerebrovascular reactivity amplifies the CO2 effect on anxiety. Even at atmospheric CO2 concentrations, impaired cerebrovascular reactivity caused longer apneic episodes and more anxiety, indicating that cerebrovascular reactivity is essential for normal brain function. The site-specific reactivity of vessels to CO2 is reflected by regional differences in their gene expression and the release of vasoactive factors from endothelial cells. Our data suggest the central nervous system (CNS) endothelium as a target to treat respiratory and affective disorders associated with vascular diseases.
| Original language | English |
|---|---|
| Journal | Proceedings of the National Academy of Sciences of the United States of America |
| Volume | 117 |
| Issue number | 3 |
| Pages (from-to) | 1753-1761 |
| Number of pages | 9 |
| ISSN | 0027-8424 |
| DOIs | |
| Publication status | Published - 21.01.2020 |
Funding
ACKNOWLEDGMENTS. We thank W. Häuser (Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck) for help with animal transfer organization, F. Spiecker (Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck) for help with RNAscope experiments, G. Patone and O. Hummel (Max Delbrück Center for Molecular Medicine, Berlin) for help with microarray experiments, and M.-G. Ludwig and K. Seuwen (Novartis) for providing Gpr4 and Gpr68 knock-out mice. The research leading to these results received funding from the Deutsche Forschungsgemeinschaft (GRK1957 “Adipocyte-Brain Crosstalk”; FOR2372 to E.K.; SCHW 416/5-2 to M.S.), from the European Research Council under the European Union’s Horizon 2020 research and innovation programme (grant agreement No. 810331 to M.S.), and the Swiss National Science Foundation (31003A_176125 to C.A.W.).
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)
DFG Research Classification Scheme
- 2.22-17 Endocrinology, Diabetology, Metabolism